| Citation: |
ZHOU Qi, LI Qinyuan, HE Hongfeng, PENG Dongrui, ZHANG Huayu, WANG Ye, YANG Kehu, CHEN Yaolong. A Standardized Approach to Recommending Diagnostic Criteria in Chinese Clinical Practice Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1432-1438. DOI: 10.12290/xhyxzz.2024-0729
|
Diagnostic criteria, as a critical component of clinical practice guidelines, play a direct role in guiding clinicians' diagnostic and treatment decisions. Although China has increasingly emphasized the development and updating of clinical guidelines in recent years, research focusing on the diagnostic criteria within these guidelines remains limited. This paper aims to explore the types of diagnostic criteria, the issues they present, and the processes involved in their formulation. Based on this analysis, suggestions are proposed to improve the recommendation and application of diagnostic criteria in Chinese guidelines.
| [1] |
Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust[M]. Washington, D, C. : National Academies Press, 2011.
|
| [2] |
Chen Y L, Wang C, Shang H C, et al. Clinical practice guidelines in China[J]. BMJ, 2018, 360: j5158.
|
| [3] |
Singh H, Graber M L. Improving diagnosis in health care-the next imperative for patient safety[J]. N Engl J Med, 2015, 373(26): 2493-2495. DOI: 10.1056/NEJMp1512241
|
| [4] |
Mestre T A, Fabbri M, Luo S, et al. A unified framework for evidence-based diagnostic criteria programs in movement disorders[J]. Mov Disord, 2023, 38(7): 1156-1162. DOI: 10.1002/mds.29420
|
| [5] |
Committee on Diagnostic Error in Health Care, Board on Health Care Services, Institute of Medicine, et al. Improving diagnosis in health care[M]. Washington, D, C. : National Academies Press, 2015.
|
| [6] |
Zhou Q, He H F, Li Q Y, et al. The characteristics, development methods, reporting quality, and evidence basis of diagnostic criteria in China between 1965 and 2023: a cross-sectional study[J]. J Evid Based Med, 2024, 17(2): 399-408. DOI: 10.1111/jebm.12624
|
| [7] |
Zhou Q, Wang Z J, Shi Q L, et al. Clinical epidemiology in China series. paper 4: the reporting and methodological quality of Chinese clinical practice guidelines published between 2014 and 2018: a systematic review[J]. J Clin Epidemiol, 2021, 140: 189-199. DOI: 10.1016/j.jclinepi.2021.08.013
|
| [8] |
陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则(2022版)[J]. 中华医学杂志, 2022, 102(10): 697-703.
Chen Y L, Yang K H, Wang X Q, et al. Guiding principles for the development/revision of clinical diagnosis and treatment guidelines in China (2022 edition)[J]. Natl Med J China, 2022, 102(10): 697-703.
|
| [9] |
Tian C, Xu M, Wang Y Y, et al. Barriers and strategies of clinical practice guideline implementation in China: aggregated analysis of 16 cross-sectional surveys[J]. J Public Health, 2024, 32(10): 1891-1904. DOI: 10.1007/s10389-023-01949-7
|
| [10] |
Yang N, Liu H, Zhao W, et al. Development of the scientific, transparent and applicable rankings (STAR) tool for clinical practice guidelines[J]. Chin Med J (Engl), 2023, 136(12): 1430-1438. DOI: 10.1097/CM9.0000000000002713
|
| [11] |
Schünemann H J, Wiercioch W, Brozek J, et al. GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT[J]. J Clin Epidemiol, 2017, 81: 101-110. DOI: 10.1016/j.jclinepi.2016.09.009
|
| [12] |
Klugar M, Lotfi T, Darzi A J, et al. GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses[J]. J Clin Epidemiol, 2024, 174: 111494. DOI: 10.1016/j.jclinepi.2024.111494
|
| [13] |
Dizon J M, Machingaidze S, Grimmer K. To adopt, to adapt, or to contextualise? The big question in clinical practice guideline development[J]. BMC Res Notes, 2016, 9(1): 442. DOI: 10.1186/s13104-016-2244-7
|
| [14] |
中华医学会神经病学分会神经免疫学组. 多发性硬化诊断与治疗中国指南(2023版)[J]. 中华神经科杂志, 2024, 57(1): 10-23. DOI: 10.3760/cma.j.cn113694-20230918-00173
Neuroimmunology Group, Neurology Branch, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of multiple sclerosis(2023 edition)[J]. Chin J Neurol, 2024, 57(1): 10-23. DOI: 10.3760/cma.j.cn113694-20230918-00173
|
| [15] |
Thompson A J, Banwell B L, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria[J]. Lancet Neurol, 2018, 17(2): 162-173. DOI: 10.1016/S1474-4422(17)30470-2
|
| [16] |
中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南(2021版)[J]. 中华皮肤科杂志, 2021, 54(4): 279-288.
Rosacea Research Center, Chinese Society of Dermatology, Rosacea Professional Committee, Chinese Dermatologist Association. Guidelines for the diagnosis and treatment of rosacea in China (2021 edition)[J]. Chin J Dermatol, 2021, 54(4): 279-288.
|
| [17] |
中国医师协会皮肤科医师分会皮肤美容亚专业委员会. 中国玫瑰痤疮诊疗专家共识(2016)[J]. 中华皮肤科杂志, 2017, 50(3): 156-161.
Skin Beauty Sub Professional Committee of the Dermatology Branch of the Chinese Medical Association. Diagnosis and treatment of rosacea in China: an expert consensus statement (2016)[J]. Chin J Dermatol, 2017, 50(3): 156-161.
|
| [18] |
中华人民共和国国家卫生健康委员会, 国家中医药管理局. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知[ EB/OL ]. (2020-02-05)[2024-09-10]. https://www.gov.cn/zhuanti/2020-02/05/content_5474791.htm.
National Health Commission of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on printing and distributing the diagnosis and treatment plan for pneumonia infected by novel coronavirus (trial version 5)[EB/OL ]. (2020-02-05)[2024-09-10]. https://www.gov.cn/zhuanti/2020-02/05/content_5474791.htm.
|
| [19] |
Sanabria A J, Kotzeva A, Selva Olid A, et al. Most guideline organizations lack explicit guidance in how to incorporate cost considerations[J]. J Clin Epidemiol, 2019, 116: 72-83. DOI: 10.1016/j.jclinepi.2019.08.004
|
| [20] |
Doust J, Vandvik P O, Qaseem A, et al. Guidance for modifying the definition of diseases: a checklist[J]. JAMA Intern Med, 2017, 177(7): 1020-1025. DOI: 10.1001/jamainternmed.2017.1302
|
| [21] |
Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development[J]. Semin Arthritis Rheum, 2011, 41(2): 95-105. DOI: 10.1016/j.semarthrit.2010.12.001
|
| [22] |
世界中医药学会联合会, 呼吸疾病中医药防治省部共建协同创新中心, 河南中医药大学, 等. 中医证候诊断标准研制指南[J]. 中国循证医学杂志, 2023, 23(9): 993-998.
World Federation of Chinese Medicine Societies, Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P. R. China, Henan University of Chinese Medicine, et al. Guideline on establishing diagnostic criteria of Chinese medicine syndromes[J]. Chin J Evid Based Med, 2023, 23(9): 993-998.
|
| [23] |
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159. DOI: 10.1136/annrheumdis-2018-214819
|
| [1] | GONG Liyun, WANG Xiaomei, PENG Guoqing, YU Huan, TAO Xiaoman. Reporting Guidelines for Healthcare Guideline Adaptations: An Interpretation of the RIGHT-Ad@pt Checklist[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 204-215. DOI: 10.12290/xhyxzz.2024-0063 |
| [2] | ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605 |
| [3] | YAO Ru, YANG Xu, QU Yang, LIAN Jie, ZHANG Jiahui, HUANG Xin, CHEN Chang, REN Xinyu, PAN Bo, ZHOU Yidong, SUN Qiang. PTEN Mutation Related Unilateral Multicentric, Synchronous and Metachronous Bilateral Breast Cancer: Three Case Reports[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 916-920. DOI: 10.12290/xhyxzz.2023-0550 |
| [4] | ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476 |
| [5] | LI Wendao, GU Hao, WANG Wei, WU Runhui, SONG Hongmei. First Case Report of FOXN1 Haploinsufficiency in China and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 366-372. DOI: 10.12290/xhyxzz.2022-0040 |
| [6] | LI Zhenghong, QUAN Meiying. Quality Improvement Project in the Healthcare Field and Standards for Quality Improvement Reporting Excellence[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1074-1080. DOI: 10.12290/xhyxzz.2022-0210 |
| [7] | LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271 |
| [8] | Yao-long CHEN, Ke-hu YANG. How to Correctly Understand, Develop, and Apply Clinical Practice Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(4): 367-373. DOI: 10.3969/j.issn.1674-9081.2018.04.015 |
| [10] | Jing YANG, Bao-lai HUA, Shu-jie WANG, Chang-wen GE, Lian-kai FAN, Ye-hua HAN, Yong-qiang ZHAO. Fechtner Syndrome in a Chinese Family: A Case Report and Literature Review[J]. Medical Journal of Peking Union Medical College Hospital, 2010, 1(2): 171-175. |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: